SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-051642
Filing Date
2020-04-27
Accepted
2020-04-27 16:38:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2016930d2_424b5.htm 424B5 410326
2 GRAPHIC image_001.jpg GRAPHIC 8584
3 GRAPHIC image_002.jpg GRAPHIC 2789
4 GRAPHIC image_004.jpg GRAPHIC 8598
  Complete submission text file 0001104659-20-051642.txt   439316
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237142 | Film No.: 20820598
SIC: 2836 Biological Products, (No Diagnostic Substances)